DexCom Inc. Files 2025 Proxy Statement
Ticker: DXCM · Form: DEF 14A · Filed: 2025-03-27T00:00:00.000Z
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: DXCM
TL;DR
DexCom's proxy statement is out, detailing exec pay and governance for 2024. Vote wisely.
AI Summary
DexCom Inc. filed its DEF 14A on March 27, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key figures related to stock awards for both PEO and Non-PEO members are presented for the fiscal years 2020 through 2024.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and corporate governance, enabling informed voting decisions on company matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing detailing executive compensation and corporate governance, not indicating new operational risks.
Key Numbers
- 2024 — Fiscal Year End (Data presented for this year)
- 2023 — Fiscal Year End (Data presented for this year)
- 2022 — Fiscal Year End (Data presented for this year)
- 2021 — Fiscal Year End (Data presented for this year)
- 2020 — Fiscal Year End (Data presented for this year)
Key Players & Entities
- DEXCOM INC (company) — Filer
- 0001093557-25-000100.txt (document) — Filing document name
- 20250327 (date) — Filing date
- 20250508 (date) — Period of report
- 3841 (number) — Standard Industrial Classification
- DE (state) — State of incorporation
- 1231 (date) — Fiscal year end
- 000-51222 (number) — SEC file number
- SAN DIEGO (city) — Business address city
- 92121 (zip_code) — Business address zip
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit proxies from shareholders when a company is holding an annual or special meeting of security holders. It provides detailed information about matters to be voted on, including director elections, executive compensation, and other corporate actions.
When was this DEF 14A filing submitted by DexCom Inc.?
DexCom Inc. submitted this DEF 14A filing on March 27, 2025.
What fiscal period does this filing primarily cover?
This filing pertains to the fiscal year ending December 31, 2024, and includes comparative data for previous fiscal years (2020-2023).
What specific types of compensation data are detailed in the filing for PEO and Non-PEO members?
The filing details deductions for amounts reported under stock awards, year-end fair value of equity awards granted that remained unvested, and vesting date fair value for awards granted and vested in the same fiscal year for both PEO (Principal Executive Officer) and Non-PEO (Non-Principal Executive Officer) members.
Where is DexCom Inc. headquartered?
DexCom Inc. is headquartered in San Diego, California, with its business address listed as 6340 Sequence Drive, San Diego, CA 92121.
From the Filing
0001093557-25-000100.txt : 20250327 0001093557-25-000100.hdr.sgml : 20250327 20250327090148 ACCESSION NUMBER: 0001093557-25-000100 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20250508 FILED AS OF DATE: 20250327 DATE AS OF CHANGE: 20250327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 25775579 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 DEF 14A 1 dxcm-20250327.htm DEF 14A dxcm-20250327 DEF 14A false 0001093557 iso4217:USD 0001093557 2024-01-01 2024-12-31 0001093557 2023-01-01 2023-12-31 0001093557 2022-01-01 2022-12-31 0001093557 2021-01-01 2021-12-31 0001093557 2020-01-01 2020-12-31 0001093557 dxcm:DeductionsForAmountsReportedUnderTheStockAwardsColumnInTheSummaryCompensationTableMember ecd:PeoMember 2024-01-01 2024-12-31 0001093557 dxcm:DeductionsForAmountsReportedUnderTheStockAwardsColumnInTheSummaryCompensationTableMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001093557 dxcm:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001093557 dxcm:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001093557 dxcm:VestingDateFairValueForAwardsGrantedAndVestedInTheSameFiscalYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001093557 dxcm:VestingDateFairValueForAwardsGrantedAndVestedInTheSameFiscalYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001093557 dxcm:ChangeInYearEndFairValueOfEquityAwardsGrantedDuringPriorYearsThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001093557 dxcm:ChangeInYearEndFairValueOfEquityAwardsGrantedDuringPriorYearsThatRemainedUnvestedAsOfTheEndOfTheCoveredYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001093557 dxcm:ChangeInFairValueFromPriorYearEndToVestingDateForAwardsGrantedInPriorYearsThatVestedInCoveredFiscalYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001093557 dxcm:ChangeInFairValueFromPriorYearEndToVestingDateForAwardsGrantedInPriorYearsThatVestedInCoveredFiscalYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001093557 dxcm:PriorYearEndFairValueForAwardsGrantedInPriorYearsThatAreForfeitedDuringTheCoveredYearMember ecd:PeoMember 2024-01-01 2024-12-31 0001093557 dxcm:PriorYearEndFairValueForAwardsGrantedInPriorYearsThatAreForfeitedDuringTheCoveredYearMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001093557 1 2024-01-01 2024-12-31 0001093557 2 2024-01-01 2024-12-31 0001093557 3 2024-01-01 2024-12-31 Table of Content s UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     ) Filed by the Registrant   ý Filed by a party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.14a-12 DexCom, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): ý No fee required ☐ Fee paid previously with preliminary materials ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act R